Oxford Biomedica plc (LON:OXB)
499.00
+9.00 (1.84%)
Sep 25, 2026, 1:29 PM GMT
Oxford Biomedica Employees
Oxford Biomedica had 977 employees as of December 31, 2025. The number of employees increased by 127 or 14.94% compared to the previous year.
Employees
977
Change (1Y)
127
Growth (1Y)
14.94%
Revenue / Employee
172.43K GBP
Profits / Employee
-40.05K GBP
Market Cap
593.09M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 977 | 127 | 14.94% |
| Dec 31, 2024 | 850 | 147 | 20.91% |
| Dec 31, 2023 | 703 | -191 | -21.36% |
| Dec 31, 2022 | 894 | 89 | 11.06% |
| Dec 31, 2021 | 805 | 132 | 19.61% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Genus | 3,190 |
| Oxford Nanopore Technologies | 1,314 |
| 4basebio | 140 |
| PureTech Health | 90 |
| Avacta Group | 81 |
| Scancell Holdings | 60 |
| Faron Pharmaceuticals Oy | 36 |
| Poolbeg Pharma | 15 |
Oxford Biomedica News
- 2 days ago - Oxford Biomedica H1 Earnings Call Highlights - MarketBeat
- 3 days ago - Oxford Biomedica Earnings Call Transcript: H1 2026 - Transcripts
- 3 days ago - Oxford Biomedica Quarterly report: H1 2026 - Filings
- 3 days ago - Oxford Biomedica Slides: H1 2026 - Filings
- 5 weeks ago - Oxford Biomedica downgraded to Hold from Buy at Deutsche Bank - TheFly
- 5 weeks ago - Oxford Biomedica downgraded to Hold from Buy at Investec - TheFly
- 6 weeks ago - Oxford Biomedica price target lowered to 900 GBp from 1,140 GBp at RBC Capital - TheFly
- 7 weeks ago - UK's Oxford Biomedica tumbles after annual revenue forecast cut - Reuters